Jazz Pharmaceuticals (JAZZ) is up 20.8%, or $29.41 to $170.48.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JAZZ:
- Jazz Pharmaceuticals Stock Surges on Positive Phase 3 Trial Results
- Promising HERIZON-GEA Trial Results Drive Buy Rating for Jazz Pharmaceuticals’ Ziihera
- Jazz Pharmaceuticals Announces Positive Phase 3 Trial Results
- Jazz Pharmaceuticals announces top-line results from HERIZON-GEA-01 trial
- Zymeworks’ Ziihera shows efficacy in Phase 3 adenocarcinoma trial